These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 30099298

  • 1. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
    Wang Y, Niu M, Yin S, Zhang F, Shi R.
    Pharmacol Rep; 2018 Oct; 70(5):917-929. PubMed ID: 30099298
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress/NO pathway: Comparison with captopril.
    Wang Y, An W, Zhang F, Niu M, Liu Y, Shi R.
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1135-1148. PubMed ID: 29935093
    [Abstract] [Full Text] [Related]

  • 3. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
    Wang Y, Zhang M, Liu Y, Liu Y, Chen M.
    Vascul Pharmacol; 2011 Nov; 54(1-2):36-43. PubMed ID: 21167314
    [Abstract] [Full Text] [Related]

  • 4. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
    Wang Y, Zhang F, Liu Y, Yin S, Pang X, Li Z, Wei Z.
    Clin Exp Hypertens; 2017 Nov; 39(7):628-639. PubMed ID: 28640644
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF, Garbin U, Stranieri C, Boccioletti V, Mozzini C, Manfro S, Pasini A, Cominacini M, Cominacini L.
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C.
    Helle F, Hultström M, Skogstrand T, Palm F, Iversen BM.
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F78-86. PubMed ID: 18945823
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
    Sasser JM, Cunningham MW, Baylis C.
    Am J Physiol Renal Physiol; 2014 Dec 15; 307(12):F1355-62. PubMed ID: 25298524
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD, Ye JM, Fu XM, Wang XC, Ye JY, Wu XR, Hua P, Liao YQ, Xuan W, Duan JL, Li WY, Fu H, Xia ZH, Zhang X.
    Int J Mol Med; 2019 Feb 15; 43(2):749-760. PubMed ID: 30569164
    [Abstract] [Full Text] [Related]

  • 13. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug 15; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 14. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 15. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Onozato ML, Tojo A, Leiper J, Fujita T, Palm F, Wilcox CS.
    Diabetes; 2008 Jan 20; 57(1):172-80. PubMed ID: 17909098
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
    Cheng MC, Wu TH, Huang LT, Tain YL.
    Pediatr Neonatol; 2014 Jun 20; 55(3):189-95. PubMed ID: 24268813
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug 20; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.